scispace - formally typeset
Open AccessJournal ArticleDOI

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.

Reads0
Chats0
TLDR
In this article, the authors evaluated the neutralization potency of 99 individuals that received one or two doses of either BNT162b2 or mRNA-1273 vaccines against pseudoviruses representing 10 globally circulating strains of SARS-CoV-2.
About
This article is published in Cell.The article was published on 2021-04-29 and is currently open access. It has received 1109 citations till now. The article focuses on the topics: Vaccination & Humoral immunity.

read more

Citations
More filters
Journal ArticleDOI

Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England

TL;DR: In this paper, the authors examined trends in the prevalence of non-B.1.7 lineages in London and other English regions using passive-case detection PCR data, cross-sectional community infection surveys, genomic surveillance, and wastewater monitoring.
Journal ArticleDOI

A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.

TL;DR: The authors in this paper reviewed and provided crucial information on SARS-CoV-2 virology, vaccines and drugs being used and developed for its prevention and treatment, as well as important variant strains.
Journal ArticleDOI

Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2.

TL;DR: In this article, a combination of in silico and large-scale phylogenetic analyses showed that R203K/G204R are adaptive and associated with the emergence of the high-transmissibility SARS-CoV-2 lineage B.1.7.1.
Journal ArticleDOI

Genomic surveillance to combat COVID-19: challenges and opportunities.

TL;DR: Genomic surveillance is emerging as a vital necessity to achieve effective mitigation and containment of SARS-CoV-2 variants and other novel viruses in the COVID-19 pandemic as discussed by the authors.
References
More filters
Journal ArticleDOI

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.

TL;DR: Infection with betacoronaviruses induces multi-specific and long-lasting T cell immunity against the structural N protein, and SARS-CoV-2-reactive T cells were found in individuals who had recovered from SARS or COVID-19 and in unexposed donors, although with different patterns of immunoreactivity.
Related Papers (5)